Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInventory AverageNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Sales

Avricore Health (AVCRF) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for Avricore Health (AVCRF) over the last 16 years, with Q3 2025 value amounting to 1005.97%.

  • Avricore Health's EBITDA Margin fell 9909900.0% to 1005.97% in Q3 2025 from the same period last year, while for Sep 2025 it was 85.61%, marking a year-over-year decrease of 878300.0%. This contributed to the annual value of 13.98% for FY2024, which is 61400.0% up from last year.
  • As of Q3 2025, Avricore Health's EBITDA Margin stood at 1005.97%, which was down 9909900.0% from 1602.16% recorded in Q2 2025.
  • Over the past 5 years, Avricore Health's EBITDA Margin peaked at 16.9% during Q1 2023, and registered a low of 1602.16% during Q2 2025.
  • In the last 5 years, Avricore Health's EBITDA Margin had a median value of 42.97% in 2021 and averaged 254.76%.
  • Per our database at Business Quant, Avricore Health's EBITDA Margin surged by 8719900bps in 2022 and then tumbled by -16073300bps in 2025.
  • Over the past 5 years, Avricore Health's EBITDA Margin (Quarter) stood at 161.24% in 2021, then surged by 85bps to 24.43% in 2022, then skyrocketed by 118bps to 4.4% in 2023, then crashed by -1240bps to 50.14% in 2024, then tumbled by -1906bps to 1005.97% in 2025.
  • Its EBITDA Margin stands at 1005.97% for Q3 2025, versus 1602.16% for Q2 2025 and 17.81% for Q1 2025.